Hepatitis C virus (HCV) genotype 1b displays higher genetic variability of hypervariable region 1 (HVR1) than genotype 3.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
06 09 2019
Historique:
received: 10 05 2019
accepted: 20 08 2019
entrez: 8 9 2019
pubmed: 8 9 2019
medline: 23 10 2020
Statut: epublish

Résumé

Hepatitis C virus (HCV) is characterized by high genetic variability, which is manifested both at the inter-host and intra-host levels. However, its role in the clinical course of infection is less obvious. The aim of the present study was to determine the genetic variability of HCV HVR1 (hypervariable region 1) of genotype 1b and 3 in plasma of blood donors in the early seronegative stage of infection (HCV-RNA+, anti-HCV-) and in samples from chronically infected patients using next-generation sequencing. Sequencing errors were corrected, and haplotypes inferred using the ShoRAH software. Genetic diversity parameters (intra-host number of variants, number of nucleotide substitutions and diversity per site) were assessed by DNA SP and MEGA. During the early infection, the number of variants were significantly lower in subjects infected with genotype 3 than with genotype 1b (p < 0.02). Similarly, intra-host number of variants, number of nucleotide substitutions and diversity per site were lower in genotype 3 chronic infection (p < 0.0005). In addition, early infection was characterized by significantly lower HVR1 variability values (p < 0.04) when compared to chronic infection for both genotypes. It seems that the observed differences in HVR1 variability represent an inherent property of particular viral genotypes.

Identifiants

pubmed: 31492939
doi: 10.1038/s41598-019-49258-y
pii: 10.1038/s41598-019-49258-y
pmc: PMC6731259
doi:

Substances chimiques

Nucleotides 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

12846

Références

J Viral Hepat. 2000 Jul;7(4):250-7
pubmed: 10886533
J Clin Microbiol. 2004 Sep;42(9):4223-9
pubmed: 15365015
BMC Bioinformatics. 2011 Apr 26;12:119
pubmed: 21521499
J Med Virol. 2001 Nov;65(3):505-9
pubmed: 11596085
Mol Biol Evol. 2011 Oct;28(10):2731-9
pubmed: 21546353
Nat Rev Genet. 2008 Apr;9(4):267-76
pubmed: 18319742
Microbiol Mol Biol Rev. 2012 Jun;76(2):159-216
pubmed: 22688811
Virology. 1992 May;188(1):331-41
pubmed: 1314459
PLoS One. 2010 Oct 25;5(10):e13619
pubmed: 21049051
PLoS Pathog. 2009 Jan;5(1):e1000274
pubmed: 19165325
Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7
pubmed: 18490657
Hepatology. 1993 Dec;18(6):1293-9
pubmed: 8244252
Transfusion. 2004 Dec;44(12):1706-10
pubmed: 15584984
J Virol. 2004 Oct;78(19):10582-7
pubmed: 15367625
J Virol. 2009 Nov;83(22):11456-66
pubmed: 19740991
Bioinformatics. 2009 Jun 1;25(11):1451-2
pubmed: 19346325
Nucleic Acids Res. 2010 Nov;38(21):7400-9
pubmed: 20671025
Clin Exp Hepatol. 2016 Dec;2(4):144-148
pubmed: 28856279
J Hepatol. 1998 Jun;28(6):939-44
pubmed: 9672167
Hepatology. 2014 Jan;59(1):318-27
pubmed: 24115039
Biomed Res Int. 2013;2013:626083
pubmed: 23710455
Virology. 2006 Sep 1;352(2):357-67
pubmed: 16781757
J Virol. 2005 Apr;79(7):4340-6
pubmed: 15767434
BMC Infect Dis. 2014 Jul 13;14:389
pubmed: 25016390
PLoS Pathog. 2011 Sep;7(9):e1002243
pubmed: 21912520
Semin Liver Dis. 2000;20(1):103-26
pubmed: 10895435
Science. 2000 Apr 14;288(5464):339-44
pubmed: 10764648
J Clin Virol. 2013 Oct;58(2):346-50
pubmed: 23523339
PLoS Pathog. 2012;8(8):e1002880
pubmed: 22927816
Gastroenterology. 2004 Sep;127(3):764-76
pubmed: 15362033

Auteurs

Maciej Janiak (M)

Department of Immunopathology of Infectious and Parasitic Diseases, Medical University of Warsaw, Warsaw, Poland.

Karol Perlejewski (K)

Department of Immunopathology of Infectious and Parasitic Diseases, Medical University of Warsaw, Warsaw, Poland.

Piotr Grabarczyk (P)

Department of Virology, Institute of Hematology and Transfusiology, Warsaw, Poland.

Dorota Kubicka-Russel (D)

Department of Virology, Institute of Hematology and Transfusiology, Warsaw, Poland.

Osvaldo Zagordi (O)

Institute of Medical Virology, University of Zurich, Zurich, Switzerland.

Hanna Berak (H)

Outpatient Clinic, Warsaw Hospital for Infectious Diseases, Warsaw, Poland.

Sylwia Osuch (S)

Department of Immunopathology of Infectious and Parasitic Diseases, Medical University of Warsaw, Warsaw, Poland.

Agnieszka Pawełczyk (A)

Department of Immunopathology of Infectious and Parasitic Diseases, Medical University of Warsaw, Warsaw, Poland.

Iwona Bukowska-Ośko (I)

Department of Immunopathology of Infectious and Parasitic Diseases, Medical University of Warsaw, Warsaw, Poland.

Rafał Płoski (R)

Department of Medical Genetics, Medical University of Warsaw, Warsaw, Poland.

Tomasz Laskus (T)

Department of Adult Infectious Diseases, Medical University of Warsaw, Warsaw, Poland.

Kamila Caraballo Cortés (K)

Department of Immunopathology of Infectious and Parasitic Diseases, Medical University of Warsaw, Warsaw, Poland. kcaraballo@wum.edu.pl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH